The ViroQ SARS-FluA/B-RSV Kit is used for qualitative detection of SARS-CoV-2, Influenza A, Influenza B and RSV (Respiratory Syncytial Virus) RNA in the samples taken from the throat-nasal swab based on reverse transcription of the RNA and subsequent amplification in real-time PCR.
Rapid immunochromatographic test for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B, RSV and Adenovirus from nasopharyngeal swabs samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) and/or Adenovirus infection.
Simple, non-invasive and highly sensitivity immunoassay to make a presumptive diagnosis of SARS-CoV-2, and/or Influenza type A, influenza type B, and/or RSV and/or Adenovirus infection.
Rapid immunochromatographic test for the qualitative detection of SARS-CoV-2, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2 / Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.
The Anti-SARS-CoV-2 NCP ELISA (IgM) test kit is used for semiquantitative determination of human antibodies of the
immunoglobulin class IgM against SARS-CoV-2 NCP (nucleocapsid
protein) in serum, EDTA, or citrate
plasma to support the diagnosis of SARS-CoV-2 infection and constitutes a
supplement to the direct pathogen detection.
The ViroQ SARS-FluA/B-RSV Kit is used for qualitative detection of SARS-CoV-2, Influenza A, Influenza B and RSV (Respiratory Syncytial Virus) RNA in the samples taken from the throat-nasal swab based on reverse transcription of the RNA and subsequent amplification in real-time PCR.
The Anti-SARS-CoV2 (IgA) ELISA test kit is used for semiquantitative determination of human antibodies of the immunoglobulin class IgA against SARS-CoV-2 in serum, EDTA, heparin or citrate plasma to support the diagnosis of SARS-CoV-2 infection and constitutes a supplement to the direct pathogen detection.
The Anti-SARS-CoV2 (IgG) ELISA test kit is used for semiquantitative determination of human antibodies of the immunoglobulin class IgG against SARS-CoV-2 in serum, EDTA, heparin or citrate plasma to support the diagnosis of SARS-CoV-2 infection and constitutes a supplement to the direct pathogen detection.
Lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or plasma specimen.
The MutaPLEX® Coronavirus (SARS-CoV-2) real time RT-PCR Kit is a screening assay for the simultaneous detection of RNA of novel coronavirus (SARS-CoV-2) and other Betacoronaviruses (e.g. MERS-CoV, SARS-CoV) extracted from biological specimens (e.g. swabs, sputum, stool).
The COVID-19 IgM ELISA kit is used for the qualitative detection of novel coronavirus infected pneumonia cases, patients with suspected cluusstering case and other new coronaviruses in serum or plasma sampple (COVID-19) that require diagnosis or differential diagnosis of newew coro coronavirus infections through measurement of the COVID-19 IgM antibody.
The COVID-19 IgG ELISA kit is used for the qualitative detection of novel coronavirus infected pneumonia cases, patients with suspected cluusstering case and other new coronaviruses in serum or plasma sampple (COVID-19) that require diagnosis or differential diagnosis of newew coro coronavirus infections through measurement of the COVID-19 IgG antibody.
